| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |